Kenan Turnacioglu
Vorsitzender bei Paige.Ai, Inc.
Aktive Positionen von Kenan Turnacioglu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Vorsitzender | 01.01.2017 | - |
Direktor/Vorstandsmitglied | 01.01.2017 | - |
Karriereverlauf von Kenan Turnacioglu
Ehemalige bekannte Positionen von Kenan Turnacioglu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Mitglied des Investmentausschusses | 01.06.2020 | 31.10.2021 |
Private Equity Investor | 01.06.2020 | 31.10.2021 | |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.01.2013 | 01.01.2016 |
Nyu Langone Cancer Center | Direktor/Vorstandsmitglied | 01.01.2010 | 01.01.2015 |
Duquesne Capital Management LLC
Duquesne Capital Management LLC Investment ManagersFinance Founded in 1981 by Stanley Druckenmiller, Duquesne Capital Management LLC is a hedge fund manager located in Pittsburgh, Pennsylvania with an additional office in New York City | Analyst-Equity | - | 31.10.2010 |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Direktor/Vorstandsmitglied | 01.01.2004 | 01.01.2007 |
Immunai, Inc.
Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.10.2020 | - |
HEAR CATA | Direktor/Vorstandsmitglied | - | - |
PointState Capital LP
PointState Capital LP Investment ManagersFinance PointState Capital LP is an independent, SEC-registered investment manager and hedge fund manager headquartered in New York City. The firm was founded in 2011 by Joshua Samuelson and Zachary Schreiber. PointState Capital provides discretionary investment advisory services, which include but not limited to, managing and directing the investment and reinvestment of assets for private investment funds and has provided these services to a discretionary separately managed account. Investors in the PointState Funds primarily consist of charitable foundations, institutions, endowments, funds of funds, private or family-owned investment entities, trusts and high net-worth individuals. | Gründer | 01.01.2011 | - |
Ausbildung von Kenan Turnacioglu
University of Pennsylvania | Doctorate Degree |
Rutgers State University of New Jersey | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 6 |
Analyst-Equity | 1 |
Doctorate Degree | 1 |
Sektoral
Finance | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 9 |
---|---|
Duquesne Capital Management LLC
Duquesne Capital Management LLC Investment ManagersFinance Founded in 1981 by Stanley Druckenmiller, Duquesne Capital Management LLC is a hedge fund manager located in Pittsburgh, Pennsylvania with an additional office in New York City | Finance |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
PointState Capital LP
PointState Capital LP Investment ManagersFinance PointState Capital LP is an independent, SEC-registered investment manager and hedge fund manager headquartered in New York City. The firm was founded in 2011 by Joshua Samuelson and Zachary Schreiber. PointState Capital provides discretionary investment advisory services, which include but not limited to, managing and directing the investment and reinvestment of assets for private investment funds and has provided these services to a discretionary separately managed account. Investors in the PointState Funds primarily consist of charitable foundations, institutions, endowments, funds of funds, private or family-owned investment entities, trusts and high net-worth individuals. | Finance |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Commercial Services |
HealthCor Catalio Acquisition Corp.
HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance HealthCor Catalio Acquisition Corp. operates as a Cayman Islands exempted company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on November 18, 2020 and is headquartered in New York, NY. | Finance |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Nyu Langone Cancer Center | |
Immunai, Inc.
Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Technology Services |
- Börse
- Insiders
- Kenan Turnacioglu
- Erfahrung